Literature DB >> 19240817

Enzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases.

K A Paschos1, D Canovas, N C Bird.   

Abstract

Enzymes play a crucial role in the progression of colorectal cancer and the development of metastases. They facilitate malignant cell invasion through the degradation of the extracellular matrix, the rupture of the basement membrane and the derangement of cell-cell adhesion. Furthermore, they promote tumour cell migration and support the evolution of metastatic lesions in the liver and other organs, through multiple molecular mechanisms, including growth factor release and angiogenesis. Urokinase plasminogen activator system, matrix metalloproteinases, heparanase and autocrine motility factor constitute important enzymatic complexes which assist colorectal cancer growth, with potential clinical applications in the diagnosis and treatment of the disease.

Entities:  

Keywords:  autocrine motility factor; colorectal cancer; extracellular matrix; heparanase; metalloproteinase; metastasis; urokinase

Year:  2009        PMID: 19240817      PMCID: PMC2633249     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  71 in total

Review 1.  Matrix metalloproteinases: useful and deleterious.

Authors:  E Ganea; M Trifan; A C Laslo; G Putina; C Cristescu
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

Review 2.  Proteoglycans: structures and interactions.

Authors:  L Kjellén; U Lindahl
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

3.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.

Authors:  A Passaniti; R M Taylor; R Pili; Y Guo; P V Long; J A Haney; R R Pauly; D S Grant; G R Martin
Journal:  Lab Invest       Date:  1992-10       Impact factor: 5.662

4.  Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients. An EORTC-Receptor and Biomarker Group collaboration.

Authors:  R Riisbro; I J Christensen; H J Nielsen; N Brünner; M Nilbert; E Fernebro
Journal:  Int J Biol Markers       Date:  2005 Apr-Jun       Impact factor: 2.659

5.  Neuroleukin: a lymphokine product of lectin-stimulated T cells.

Authors:  M E Gurney; B R Apatoff; G T Spear; M J Baumel; J P Antel; M B Bania; A T Reder
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

6.  Sequencing complex polysaccharides.

Authors:  G Venkataraman; Z Shriver; R Raman; R Sasisekharan
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

Review 7.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

8.  Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression.

Authors:  Arayo Haga; Tatsuyoshi Funasaka; Yasufumi Niinaka; Avraham Raz; Hisamitsu Nagase
Journal:  Int J Cancer       Date:  2003-12-10       Impact factor: 7.396

9.  Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis.

Authors:  Alexandre Loktionov; Mark A Watson; William S L Stebbings; Chris T M Speakman; Sheila A Bingham
Journal:  Cancer Lett       Date:  2003-01-28       Impact factor: 8.679

10.  Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells.

Authors:  M Miyaki; K Tanaka; R Kikuchi-Yanoshita; M Muraoka; M Konishi; M Takeichi
Journal:  Oncogene       Date:  1995-12-21       Impact factor: 9.867

View more
  3 in total

1.  Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients.

Authors:  Fee Klupp; Lena Neumann; Christoph Kahlert; Johannes Diers; Niels Halama; Clemens Franz; Thomas Schmidt; Moritz Koch; Juergen Weitz; Martin Schneider; Alexis Ulrich
Journal:  BMC Cancer       Date:  2016-07-18       Impact factor: 4.430

Review 2.  Molecular functions of thyroid hormones and their clinical significance in liver-related diseases.

Authors:  Hsiang Cheng Chi; Cheng-Yi Chen; Ming-Ming Tsai; Chung-Ying Tsai; Kwang-Huei Lin
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

Review 3.  Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II.

Authors:  Matej Horvat; Uroš Potočnik; Katja Repnik; Rajko Kavalar; Borut Štabuc
Journal:  Gastroenterol Res Pract       Date:  2016-01-14       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.